These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7659302)

  • 41. Characterization of CCKA receptor mediated pepsinogen secretion in porcine chief cells.
    Meyer G; Beinborn M; Sewing KF
    Pharmacology; 1996 Jul; 53(1):48-59. PubMed ID: 8875601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
    Zhou Y; Sun YH; Zhang ZW; Han JS
    Eur J Pharmacol; 1993 Apr; 234(2-3):147-54. PubMed ID: 8387008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion.
    Luckman SM; Hamamura M; Antonijevic I; Dye S; Leng G
    Br J Pharmacol; 1993 Sep; 110(1):378-84. PubMed ID: 8220899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CCK-8, CCK-4 and gastrin-induced contractions in guinea pig ileum: evidence for differential release of acetylcholine and substance P by CCK-A and CCK-B receptors.
    Lucaites VL; Mendelsohn LG; Mason NR; Cohen ML
    J Pharmacol Exp Ther; 1991 Feb; 256(2):695-703. PubMed ID: 1704435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
    Pu SF; Zhuang HX; Han JS
    Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
    Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
    Br J Pharmacol; 1992 May; 106(1):61-6. PubMed ID: 1504732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An evaluation of the influence of devazepide and CCK-8S on the intact and resected rat liver.
    Ohlsson B; Rehfeld JF; Axelson J
    Eur Surg Res; 1998; 30(6):378-84. PubMed ID: 9838229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversal of CRF- and dopamine-induced stimulation of colonic motility by CCK and igmesine (JO 1784) in the rat.
    Gué M; Gleïzes-Escala C; Del Rio-Lacheze C; Junien JL; Buéno L
    Br J Pharmacol; 1994 Mar; 111(3):930-4. PubMed ID: 7912631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice.
    Derrien M; Noble F; Maldonado R; Roques BP
    Neurosci Lett; 1993 Oct; 160(2):193-6. PubMed ID: 8247353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CCK satiety is differentially mediated by high- and low-affinity CCK receptors in mice and rats.
    Weatherford SC; Laughton WB; Salabarria J; Danho W; Tilley JW; Netterville LA; Schwartz GJ; Moran TH
    Am J Physiol; 1993 Feb; 264(2 Pt 2):R244-9. PubMed ID: 8447480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cholecystokinin inhibits food intake at a peripheral extragastric site.
    Zittel TT; Elm BV; Teichmann RK; Becker HD; Raybould HE
    Ann N Y Acad Sci; 1994 Mar; 713():431-4. PubMed ID: 8185211
    [No Abstract]   [Full Text] [Related]  

  • 52. CCK-8 activates hepatic vagal C-fiber afferents.
    Cox JE; Randich A
    Brain Res; 1997 Nov; 776(1-2):189-94. PubMed ID: 9439812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.
    Marshall FH; Barnes S; Pinnock RD; Hughes J
    Br J Pharmacol; 1990 Apr; 99(4):845-8. PubMed ID: 2361176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Partial agonism by gastrin for a cholecystokinin receptor mediating pepsinogen secretion.
    Tang LH; Miller MD; Goldenring JR; Modlin IM; Hersey SJ
    Am J Physiol; 1993 Nov; 265(5 Pt 1):G865-72. PubMed ID: 8238515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrophysiological recordings from rat hippocampus slices following in vivo brain ischemia.
    Jensen MS; Lambert JD; Johansen FF
    Brain Res; 1991 Jul; 554(1-2):166-75. PubMed ID: 1657285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholecystokinin-A receptor mediation of food intake in cats.
    Bado A; Durieux C; Moizo L; Roques BP; Lewin MJ
    Am J Physiol; 1991 Apr; 260(4 Pt 2):R693-7. PubMed ID: 2012242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influences of cholecystokinin octapeptide on phosphoinositide turnover in neonatal-rat brain cells.
    Zhang LJ; Lu XY; Han JS
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):847-50. PubMed ID: 1323276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Both CCK-A and CCK-B/gastrin receptors mediate pepsinogen release in guinea pig gastric glands.
    Lin CW; Bianchi BR; Miller TR; Witte DG; Wolfram CA
    Am J Physiol; 1992 Jun; 262(6 Pt 1):G1113-20. PubMed ID: 1616041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat.
    Mönnikes H; Lauer G; Arnold R
    Brain Res; 1997 Oct; 770(1-2):277-88. PubMed ID: 9372230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.